Health Economic Analysis and Methods Yvonne Jonk, PhD Educational - - PowerPoint PPT Presentation

health economic analysis and methods
SMART_READER_LITE
LIVE PREVIEW

Health Economic Analysis and Methods Yvonne Jonk, PhD Educational - - PowerPoint PPT Presentation

Health Economic Analysis and Methods Yvonne Jonk, PhD Educational Objectives Types of Economic Evaluations in Health Care Economic Perspectives: Societal, Institutional Datasets: Measures of Cost and Effectiveness Medicare Data:


slide-1
SLIDE 1

Health Economic Analysis and Methods

Yvonne Jonk, PhD

slide-2
SLIDE 2

Educational Objectives

  • Types of Economic Evaluations in Health Care
  • Economic Perspectives: Societal, Institutional
  • Datasets: Measures of Cost and Effectiveness
  • Medicare Data: Use and Implications

2

slide-3
SLIDE 3
  • I. Types of Economic Evaluations
  • Four approaches to analyzing costs:

˗ Cost Identif ific ication ation Analysis (CIA) ˗ Cost Effectiv iveness ness Analysis (CEA) ˗ Cost Benefit fit Analysis (CBA) ˗ Cost Uti tility lity Analysis (CUA)

3

Gold MR, Siegel JE, Russell LB, et al. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.

slide-4
SLIDE 4
  • I. Cost Identification Analysis (CIA)
  • Also called “Cost Minimization Analysis”
  • Answers the question, “What is the cost per

service or program?”

  • Goal is to select the least cost option
  • Assumes health outcomes are the same for the

two programs / interventions

  • Ignores benefits or health outcomes

4

slide-5
SLIDE 5
  • I. Cost Effectiveness Analysis (CEA)
  • Includes both costs and
  • utcomes
  • Numerator of Cost

Effectiveness Ratio (CER) reflects change in cost

  • Denominator reflects

change in outcome (e.g., lives saved, complications averted, cases of illness prevented)

5

 Cost ─────────  Outcome

slide-6
SLIDE 6
  • I. Cost Effectiveness Analysis (CEA)
  • Testing to see if health outcomes are the same

under two interventions/strategies

  • If one of the interventions/strategies is cheaper

and more effective, it “dominates” the other

  • If an intervention/strategy is more expensive and

more effective, it’s cost effective if the extra benefit justifies the extra cost

6

slide-7
SLIDE 7
  • I. Cost Effectiveness Analysis (CEA)
  • Can only compare interventions whose benefits

are measured in the same units of effectiveness

  • Cannot inform decisions about how much to

spend on housing, food, or education in relation to health care

7

slide-8
SLIDE 8
  • I. Cost Benefit Analysis (CBA)
  • Answers the question, “Is the benefit worth the

extra cost?”

  • Aggregates all effects (benefits and costs) into

dollar amounts

˗ This can be controversial: it involves asking consumers what they are willing to pay to avoid an injury or illness, for example

8

slide-9
SLIDE 9
  • I. Cost Benefit Analysis (CBA)
  • Provides no distinction between cost and effect,

input or outcome

  • Broader application than CEA
  • Can inform decisions about how much to spend on

housing, food, or education in relation to health care

9

slide-10
SLIDE 10
  • I. Cost Utility Analysis (CUA)
  • A variant of CEA
  • Measures outcomes in

life-years of survival or quality-adjusted life years (QALYs)

  • Can not typically

perform CUA with claims data alone…

10

 Cost ─────────  QALYs

slide-11
SLIDE 11
  • II. Economic Perspectives

Whose costs/benefits should be considered?

  • Societal Perspective (“gold standard”)

˗ Health care institutions, patients, caregivers

  • Institutional Perspective

˗ Health care institutions, third party payers

11

slide-12
SLIDE 12
  • II. Economic Perspectives

Whose costs/benefits are considered?

  • Societal Perspective(“gold standard”)

˗ Direct medical expenses

» Hospital Inpatient (IP) » Outpatient care (OP) » Prescriptions (Rx) » Supplies, labs (e.g. x-rays, blood tests, etc.)

12

slide-13
SLIDE 13
  • II. Economic Perspectives

Whose costs/benefits are considered?

  • Societal Perspective(“gold standard”)

˗ Indirect medical expenses (accounting definition)

» Overhead (utilities) » Facility (rent) » Capital financing

˗ Patient’s time (travel time, time lost from work/leisure) ˗ Caregiver’s time (travel time, time caring for patient)

13

slide-14
SLIDE 14
  • II. Economic Perspectives

Whose costs/benefits are considered?

  • Institutional Perspective: (e.g. hospital or third

party payer)

˗ Direct medical expenses

» Hospital Inpatient (IP) » Outpatient care (OP) » Prescriptions (Rx) » Supplies, labs (e.g. x-rays, blood tests)

14

slide-15
SLIDE 15
  • II. Economic Perspectives

Whose costs/benefits are considered?

  • Institutional Perspective: (e.g. hospital or third

party payer)

˗ Indirect medical expenses

» Overhead (utilities) » Facility (rent) » Capital financing

15

slide-16
SLIDE 16

Thi hird rd party ty payer

Insurance Company or Government Agency

Consum sumer ers

Patients

Pro roducer ducers

Health Care Providers

(hospitals, physicians, etc.) Charges Insurance coverage Medical Services Premiums Out of pocket fees

Financing

Reimbursement

16

slide-17
SLIDE 17

17

Thi hird rd party ty payer

Insurance Company or Government Agency

Consum sumer ers

Patients

Pro roducer ducers

Health Care Providers

(hospitals, physicians, etc.) Charges Insurance coverage Medical Services Premiums Out of pocket fees

Financing

Claims Data Reimbursement

slide-18
SLIDE 18
  • III. Datasets: Measures of Cost
  • Third

rd Par Party ty Pa Payer: er:

˗ Claims data represent reimbursement

» CMS files:

  • MedPAR
  • Standard Analytical Files (SAFs)
  • Ho

Hospi pital l or I r Insti titutio tution: n:

˗ Charges represent institutional direct costs + overhead (indirects) + profits ˗ Cost of services represent institutional direct costs

» Medicare Claims & Cost Reports cost to charge ratio

18

slide-19
SLIDE 19
  • III. Datasets: Measures of Cost
  • Societal

tal Perspec pectiv tive:

˗ Cost of services represent institutional direct costs

» Medicare claims & Cost Reports need to use cost to charge ratio

˗ If QALYs do not account for the value of patient’s time lost from work, travel costs, and value of caregiver time, include these costs in numerator of CER

» Medicare claims & Master Beneficiary Summary files contain patients’ zipcodes calculate distance traveled to see providers

» CMS files: Provider of Service (POS) files contain institutions’ zipcodes or Cost Report website ˗ NOT in CMS files:

» Time lost from work » Caregiver’s time

19

slide-20
SLIDE 20
  • III. Datasets: Measures of Effectiveness
  • QALYs - not in Medicare claims data
  • Mortality

˗ Deaths (CMS data: MedPAR, Denominator/Master Beneficiary Summary file)

  • Morbidity measures

˗ LOS in hospital (CMS data: MedPAR, SAFs) ˗ LOS in ICU (CMS data: MedPAR, SAFs) ˗ Re-interventions & complications (CMS data: MedPAR, SAFs)

20

slide-21
SLIDE 21
  • III. Datasets: Measures of Effectiveness
  • Comorbidity measures

˗ Chronic conditions: CCW Master Beneficiary Summary Files contain indicator variables for chronic conditions ˗ Risk adjustment scores: use diagnoses (Dx) codes in claims files to calculate risk adjustment scores (e.g. Charlson, ACGs)

» May want to include all SAFs (e.g. Skilled Nursing Facilities (SNF), Home Health (HH), Hospice) for

  • utpatient analyses

˗ Health & functional status measures are not in CMS claims data » e.g. # Activities of Daily Living (ADLs) » e.g. # Independent Activities of Daily Living (IADLs)

21

slide-22
SLIDE 22
  • III. Datasets: Measures of Effectiveness
  • Comorbidity measures

˗ Assessment datasets

» Minimum Data Set (MDS) – clinical assessment data for nursing home residents » Outcome and Assessment Information Set (OASIS) – assessment data for home care patients » Inpatient Rehabilitation Facilities - Patient Assessment Instrument (IRF-PAI) » Medicare Current Beneficiary Survey (MCBS) Access to Care Files – health and functional status measures

22

slide-23
SLIDE 23
  • IV. Datasets: Use and Implications
  • Medi

dicare care

  • 1. Payment or reimbursement (claims)
  • 2. Charges (vary by institutions)
  • 3. Cost (what we’re really trying to measure!)
  • 4. Cost to charge ratios (calculation)

23

slide-24
SLIDE 24
  • IV. Datasets: Use and Implications
  • Medi

dicare care

  • 1. Payment or Reimbursement

» Claims data

» May or may not cover a specific institution’s costs or charges » Offers standardized approach to measuring costs

24

slide-25
SLIDE 25
  • IV. Datasets: Use and Implications
  • Medi

dicare care

  • 2. Charges

» Lots of variation across hospitals

» Within hospitals, lots of variation across departments » Accounting systems allow for cross subsidizing across departments » In theory, no upper limit on charges

25

slide-26
SLIDE 26
  • IV. Datasets: Use and Implications
  • Medi

dicare care

  • 3. Cost (what we’re really trying to measure!)

» Derived using Cost to Charge Ratios (CCR)

  • CCR = Cost/Charge
  • Cost = Charges *CCR

» Lots of variation across hospitals in overall CCRs » Lots of variation in departmental CCRs within hospitals

26

slide-27
SLIDE 27
  • IV. Datasets: Use and Implications
  • Medi

dicare care

  • 4. Cost to Charge Ratios (CCR) = Cost/Charge

» CCR < 1  Cost < Charge  making $$ » CCR > 1  Cost > Charge  losing $$ » Accounting systems allow for cross subsidizing across departments

27